Skip to main content
Erschienen in: Clinical Research in Cardiology 8/2011

01.08.2011 | Original Paper

Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications

verfasst von: Karl Werdan, Anja Oelke, Stefan Hettwer, Sebastian Nuding, Sebastian Bubel, Robert Hoke, Martin Ruß, Christine Lautenschläger, Ursula Mueller-Werdan, Henning Ebelt

Erschienen in: Clinical Research in Cardiology | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction

In sepsis, severe reduction of afterload may often mask cardiac impairment. By establishing the parameter “afterload-related cardiac performance (ACP)” we wanted to determine the extent, frequency, and prognostic relevance of septic cardiomyopathy.

Methods

Over a 12 months period, all patients of our medical intensive care ward were included into the study when they were classified as having “septic MODS” (sepsis score ≥12 as long as APACHE II score was ≥20). Hemodynamic assessments were performed using a pulmonary artery catheter.

Results

A total of 524 patients were screened, and from these 39 had septic MODS. In survivors, APACHE II score values declined from day 0 (day of diagnosis, 27.6 ± 8.0) to day 4 (17.8 ± 8.0), while in non-survivors, score values remained high (day 0: 31.8 ± 5.7; day 4: 33.2 ± 6.7; p < 0.001). Hemodynamic measurements showed an inverse correlation of cardiac output (COmeasured) and SVR which can be described as CO = β 0 × SVR β1. The upper limit of 80% tolerance range of CO was defined as the “normal” CO values (COnormal). The parameter “afterload-related cardiac performance (ACP)” was calculated as ACP (%) = COmeasured/COnormal × 100. It turned out that ACP shows a stronger correlation with APACHE II- and sepsis-score than CO, cardiac index (CI), cardiac power (CPO), or cardiac power index (CPI). Furthermore, ACP correlated with sepsis-induced myocardial damage as indicated by elevations of troponin I and significantly differed between surviving (86.9 ± 1.6%) and non-surviving patients (69.2 ± 1.4%; p < 0.0001). While 75% of the surviving patients showed an ACP >60%, 38% of the non-survivors had a moderate (ACP 40–60%) and 25% a severe impairment of cardiac function (ACP < 40%).

Conclusion

By using the parameter “afterload-related cardiac performance, ACP”, the impairment of cardiac function can be reliably quantified showing that septic cardiomyopathy occurs frequently and is of prognostic relevance in patients with septic MODS.
Literatur
1.
Zurück zum Zitat Reinhart K, Brunkhorst F, Bone Hg et al (2006) Diagnose und Therapie der Sepsis. Clin Res Cardiol 95:429–454PubMedCrossRef Reinhart K, Brunkhorst F, Bone Hg et al (2006) Diagnose und Therapie der Sepsis. Clin Res Cardiol 95:429–454PubMedCrossRef
2.
3.
Zurück zum Zitat Werdan K, Schmidt H, Ebelt H et al (2009) Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol 87:266–274PubMedCrossRef Werdan K, Schmidt H, Ebelt H et al (2009) Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol 87:266–274PubMedCrossRef
4.
Zurück zum Zitat Kindermann M, Seeland U, Ruhnke P (2010) Functional effects of beta(1)-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without beta-blocker administration. Clin Res Cardiol. doi:10.1007/s00392-00010-00221-z Kindermann M, Seeland U, Ruhnke P (2010) Functional effects of beta(1)-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without beta-blocker administration. Clin Res Cardiol. doi:10.​1007/​s00392-00010-00221-z
5.
Zurück zum Zitat Vieillard-Baron A, Prin S, Chergui K et al (2003) Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography. Am J Respir Crit Care Med 168:1270–1276PubMedCrossRef Vieillard-Baron A, Prin S, Chergui K et al (2003) Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography. Am J Respir Crit Care Med 168:1270–1276PubMedCrossRef
7.
Zurück zum Zitat Werdan K, Pilz G, Bujdoso O et al (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 35:2693–2701PubMedCrossRef Werdan K, Pilz G, Bujdoso O et al (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 35:2693–2701PubMedCrossRef
8.
Zurück zum Zitat Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276PubMedCrossRef Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276PubMedCrossRef
9.
Zurück zum Zitat Bouhemad B, Nicolas-Robin A, Arbelot C et al (2009) Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 37:441–447PubMedCrossRef Bouhemad B, Nicolas-Robin A, Arbelot C et al (2009) Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 37:441–447PubMedCrossRef
11.
Zurück zum Zitat Werdan K, Muller-Werdan U (1996) Elucidating molecular mechanisms of septic cardiomyopathy–the cardiomyocyte model. Mol Cell Biochem 163–164:291–303PubMedCrossRef Werdan K, Muller-Werdan U (1996) Elucidating molecular mechanisms of septic cardiomyopathy–the cardiomyocyte model. Mol Cell Biochem 163–164:291–303PubMedCrossRef
12.
Zurück zum Zitat Zorn-Pauly K, Pelzmann B, Lang P et al (2007) Endotoxin impairs the human pacemaker current If. Shock 28:655–661PubMed Zorn-Pauly K, Pelzmann B, Lang P et al (2007) Endotoxin impairs the human pacemaker current If. Shock 28:655–661PubMed
13.
Zurück zum Zitat Fincke R, Hochman Js, Lowe Am et al (2004) Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 44:340–348PubMedCrossRef Fincke R, Hochman Js, Lowe Am et al (2004) Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 44:340–348PubMedCrossRef
14.
Zurück zum Zitat Pilz G, Mcginn P, Boekstegers P et al (1994) Pseudomonas sepsis does not cause more severe cardiovascular dysfunction in patients than non-Pseudomonas sepsis. Circ Shock 42:174–182PubMed Pilz G, Mcginn P, Boekstegers P et al (1994) Pseudomonas sepsis does not cause more severe cardiovascular dysfunction in patients than non-Pseudomonas sepsis. Circ Shock 42:174–182PubMed
15.
Zurück zum Zitat Levy Rj, Piel Da, Acton Pd et al (2005) Evidence of myocardial hibernation in the septic heart. Crit Care Med 33:2752–2756PubMedCrossRef Levy Rj, Piel Da, Acton Pd et al (2005) Evidence of myocardial hibernation in the septic heart. Crit Care Med 33:2752–2756PubMedCrossRef
16.
Zurück zum Zitat Spies C, Haude V, Fitzner R et al (1998) Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113:1055–1063PubMedCrossRef Spies C, Haude V, Fitzner R et al (1998) Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113:1055–1063PubMedCrossRef
17.
Zurück zum Zitat Wu Ah (2001) Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med 27:959–961PubMedCrossRef Wu Ah (2001) Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med 27:959–961PubMedCrossRef
18.
Zurück zum Zitat Brueckmann M, Huhle G, Lang S et al (2005) Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112:527–534PubMedCrossRef Brueckmann M, Huhle G, Lang S et al (2005) Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112:527–534PubMedCrossRef
19.
Zurück zum Zitat Charpentier J, Luyt Ce, Fulla Y et al (2004) Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32:660–665PubMedCrossRef Charpentier J, Luyt Ce, Fulla Y et al (2004) Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32:660–665PubMedCrossRef
20.
Zurück zum Zitat Witthaut R, Busch C, Fraunberger P et al (2003) Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29:1696–1702PubMedCrossRef Witthaut R, Busch C, Fraunberger P et al (2003) Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29:1696–1702PubMedCrossRef
21.
Zurück zum Zitat Mclean As (1996) Echocardiography assessment of left ventricular function in the critically ill. Anaesth Intensive Care 24:60–65PubMed Mclean As (1996) Echocardiography assessment of left ventricular function in the critically ill. Anaesth Intensive Care 24:60–65PubMed
Metadaten
Titel
Septic cardiomyopathy: hemodynamic quantification, occurrence, and prognostic implications
verfasst von
Karl Werdan
Anja Oelke
Stefan Hettwer
Sebastian Nuding
Sebastian Bubel
Robert Hoke
Martin Ruß
Christine Lautenschläger
Ursula Mueller-Werdan
Henning Ebelt
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 8/2011
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-011-0292-5

Weitere Artikel der Ausgabe 8/2011

Clinical Research in Cardiology 8/2011 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.